Respihale®

Home page
Medications
Respihale®

Pulmonology

Respihale®

Registration certificate:

ЛП-№(000664)-(РГ-RU)

INN:

Glycopyrronium bromide + Indacaterol

Release form:

Inhalation powder hard capsule

Therapeutic Area:

Pulmonology

Pharmacotherapeutic Group:

Drugs for the treatment of obstructive respiratory tract diseases; adrenergic agents for inhalation; adrenergic agents in combination with glucocorticoids or other agents other than anticholinergic agents.

Conditions for dispensing:

On prescription

Leaflet:

hxyr45jlkxezin466itra8muuako9us6.pdf

631kb

Packaging:

Indications for Use: Long-term maintenance therapy for bronchial obstruction in patients with chronic obstructive pulmonary disease, alleviating symptoms and reducing the frequency of exacerbations.

Prescription Status: Rx only.

CONTRAINDICATIONS APPLY. PLEASE CONSULT A SPECIALIST BEFORE USE.

For the full version of the medical instruction for Respihale®, please visit the open access website at https://grls.rosminzdrav.ru/Default.aspx